Patent 7560464 was granted and assigned to Icagen, Inc. on July, 2009 by the United States Patent and Trademark Office.
The present invention provides a genus of polycyclic pyrimidines that are useful as modulators of potassium ion channels. The modulators of the invention are of use in both therapeutic and diagnostic methods.